GANO KYLE (Chief Business Development Off) received a stock award from NEUROCRINE BIOSCIENCES INC

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award

GANO KYLE

Filed: 2/17/2026ACC: 0001567160-26-000007

InsiderGANO KYLECIK 1567160

→

IssuerNEUROCRINE BIOSCIENCES INCCIK 914475

Officer· Chief Business Development Off

Since Aug 2018

+134.32K

Net shares

Net buyer

$1.32M

Total sold

Open market trades

0B · 0S

Total transactions

154.65K acquired · 20.34K disposed

Non-Derivative Transactions8

Common Stock

Direct

M · Option Exercise

+4.91K

Price / share

—

Trade value

—

% of position

3.5%

2/12/2026

141.75K→146.66K

Common Stock

Direct

F · Tax Withholding

−2.65K

Price / share

$123.10

Trade value

$325.97K

% of position

1.8%

2/12/2026

146.66K→144.01K

Common Stock

Direct

M · Option Exercise

+2.24K

Price / share

—

Trade value

—

% of position

1.6%

2/13/2026

144.01K→146.25K

Common Stock

Direct

F · Tax Withholding

−1.21K

Price / share

$124.12

Trade value

$150.19K

% of position

0.8%

2/13/2026

146.25K→145.04K

Common Stock

Direct

M · Option Exercise

+2.57K

Price / share

—

Trade value

—

% of position

1.8%

2/13/2026

145.04K→147.61K

Common Stock

Direct

F · Tax Withholding

−1.39K

Price / share

$124.12

Trade value

$171.91K

% of position

0.9%

2/13/2026

147.61K→146.22K

Common Stock

Direct

A · Award

+9.97K

Price / share

—

Trade value

—

% of position

6.8%

2/13/2026

146.22K→156.19K

Common Stock

Direct

F · Tax Withholding

−5.38K

Price / share

$124.12

Trade value

$667.52K

% of position

3.4%

2/13/2026

156.19K→150.81K

Total

Net shares

+9.06K

Net value

-$1.32M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	2/12/2026	M · Option Exercise	+4.91K	—	—	3.5%	141.75K	146.66K
Common Stock Direct	2/12/2026	F · Tax Withholding	−2.65K	$123.10	$325.97K	1.8%	146.66K	144.01K
Common Stock Direct	2/13/2026	M · Option Exercise	+2.24K	—	—	1.6%	144.01K	146.25K
Common Stock Direct	2/13/2026	F · Tax Withholding	−1.21K	$124.12	$150.19K	0.8%	146.25K	145.04K
Common Stock Direct	2/13/2026	M · Option Exercise	+2.57K	—	—	1.8%	145.04K	147.61K
Common Stock Direct	2/13/2026	F · Tax Withholding	−1.39K	$124.12	$171.91K	0.9%	147.61K	146.22K
Common Stock Direct	2/13/2026	A · Award	+9.97K	—	—	6.8%	146.22K	156.19K
Common Stock Direct	2/13/2026	F · Tax Withholding	−5.38K	$124.12	$667.52K	3.4%	156.19K	150.81K
Total			+9.06K		-$1.32M

Derivative Transactions5

Restricted Stock Unit

Direct

M · Option Exercise

Converts to

Common Stock

4.91K shares

−4.91K

Strike price

Held after

14.72K

Exercisable

—

2/12/2026

Restricted Stock Unit

Direct

M · Option Exercise

Converts to

Common Stock

2.24K shares

−2.24K

Strike price

Held after

4.48K

Exercisable

—

2/13/2026

Restricted Stock Unit

Direct

M · Option Exercise

Converts to

Common Stock

2.57K shares

−2.57K

Strike price

Held after

2.57K

Exercisable

—

2/13/2026

Stock Option

Direct

A · Award

Converts to

Common Stock

114.83K shares

+114.83K

Strike price

124.12

Held after

114.83K

Exercisable

—

2/13/2026

Restricted Stock Unit

Direct

A · Award

Converts to

Common Stock

20.14K shares

+20.14K

Strike price

Held after

20.14K

Exercisable

—

2/13/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Restricted Stock Unit Direct	Common Stock4.91K shares	2/12/2026	M · Option Exercise	−4.91K		—	14.72K
Restricted Stock Unit Direct	Common Stock2.24K shares	2/13/2026	M · Option Exercise	−2.24K		—	4.48K
Restricted Stock Unit Direct	Common Stock2.57K shares	2/13/2026	M · Option Exercise	−2.57K		—	2.57K
Stock Option Direct	Common Stock114.83K shares	2/13/2026	A · Award	+114.83K	124.12	—	114.83K
Restricted Stock Unit Direct	Common Stock20.14K shares	2/13/2026	A · Award	+20.14K		—	20.14K